? PROTEOMICS SHARED RESOURCE FACILITY The mission of the Proteomics Shared Resource Facility is to provide cost-effective, state-of the-art instrumentation and analytical proteomics expertise to investigators in the Lurie Cancer Center (LCC). The Proteomics Core provides a full array of services including study design, sample preparation, data generation and analysis and interpretation of results. The Core supports work involving the following types of methodologies: 1) protein identification from gels and BioID samples. 2) Quantitative proteomics ? labeled and label-free. 3) Top-down proteomics - qualitative and quantitative, 4) Site-specific PTM analyses, including phosphorylation, acetylation, methylation, glycosylation, palmitoylation, and ubiquitination; 5) Targeted proteomics using selective reaction monitoring (SRM) and related methods; 6) Histone Modification Panel analysis, covering all major histone marks, and 7) Advanced proteomics sample preparation from body fluids (blood, urine, saliva, CSF), tissue, secretome, exosome, and mitochondria. In addition, the Proteomics Core staff provides education and training in sample preparation, instrumental analysis and data analysis to LCC investigators and their laboratory personnel. The Core operates eight liquid chromatography-mass spectrometry systems and since its inception as a former developing core at the time of the last CCSG review, has served over 90 LCC investigators, resulting in over 60 research publications. The Proteomics Core is located on both campuses of Northwestern University (NU). Neil Kelleher, PhD, directs the Facility and works closely with Young Ah Goo, PhD, the Operations Director of the Facility. As a cross- university, cross-campus resource, access to service is available to all Northwestern University investigators, with priority given to LCC researchers. During the next funding period, the Proteomics Core will continue to work closely with LCC researchers to ensure that efficient access and technological expertise in proteomics is available to all research teams engaged in basic, clinical and translational cancer studies.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
United States
Zip Code
Yang, Ruiguo; LemaƮtre, Vincent; Huang, Changjin et al. (2018) Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation. Small 14:e1702495
Buglak, Nicholas E; Jiang, Wulin; Bahnson, Edward S M (2018) Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats. Redox Biol 19:166-178
Takahashi, Satoe; Sun, Willy; Zhou, Yingjie et al. (2018) Prestin Contributes to Membrane Compartmentalization and Is Required for Normal Innervation of Outer Hair Cells. Front Cell Neurosci 12:211
Zheng, Jianbin; Chen, Long; Skinner, Owen S et al. (2018) ?-Glucocerebrosidase Modulators Promote Dimerization of ?-Glucocerebrosidase and Reveal an Allosteric Binding Site. J Am Chem Soc 140:5914-5924
Kenney, Grace E; Dassama, Laura M K; Pandelia, Maria-Eirini et al. (2018) The biosynthesis of methanobactin. Science 359:1411-1416
Joyce, Brian T; Zheng, Yinan; Zhang, Zhou et al. (2018) miRNA-Processing Gene Methylation and Cancer Risk. Cancer Epidemiol Biomarkers Prev 27:550-557
Chu, Lan H; Indramohan, Mohanalaxmi; Ratsimandresy, Rojo A et al. (2018) The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun 9:996
Symes, Yael R; Barrington, Clare; Austin, Jane et al. (2018) Advice to patients undergoing stem cell transplant: Content analysis of survivor peer support narratives. J Health Psychol 23:818-828
Lewis, Phillip L; Green, Richard M; Shah, Ramille N (2018) 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. Acta Biomater 69:63-70
Ugolkov, Andrey V; Bondarenko, Gennadiy I; Dubrovskyi, Oleksii et al. (2018) 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma. Anticancer Drugs 29:717-724

Showing the most recent 10 out of 1972 publications